Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo
Breast cancer is one of the most common malignant tumors in women and it is the most frequently diagnosed cancer in the world. Ampelopsin (AMP) is a purified component from the root of Ampelopsis grossedentata. It is reported that AMP could significantly inhibit the proliferation of breast cancer ce...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-03-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832545345124433920 |
|---|---|
| author | Meng Minjun Yang Qiaolu Ouyang Zhong Yang Qingmo Wu Xinyi Huang Yufan Su Yonghui Chen Shuanglong Chen Wenlin |
| author_facet | Meng Minjun Yang Qiaolu Ouyang Zhong Yang Qingmo Wu Xinyi Huang Yufan Su Yonghui Chen Shuanglong Chen Wenlin |
| author_sort | Meng Minjun |
| collection | DOAJ |
| description | Breast cancer is one of the most common malignant tumors in women and it is the most frequently diagnosed cancer in the world. Ampelopsin (AMP) is a purified component from the root of Ampelopsis grossedentata. It is reported that AMP could significantly inhibit the proliferation of breast cancer cells. However, the antitumor mechanism against breast cancer has not yet been fully elucidated. The purpose of this work was to study the role of AMP against breast cancer MDA-MB-231 cells and to further investigate the underlying mechanism. PI3K/AKT/mTOR plays a very important role in tumor cell growth and proliferation and we hypothesize that AMP may inhibit this pathway. In the present work, the results showed that AMP could significantly inhibit the growth of breast cancer MDA-MB-231 cells in vitro and in vivo. In addition, treatment with AMP decreased the levels of PI3K, AKT and mTOR, as well as cyclin B1 expression, followed by p53/p21 pathway activation to arrest the cell cycle at G2/M. Moreover, it demonstrated a positive association between cyclin B1 and PI3K/AKT/mTOR levels. Importantly, this pathway was found to be regulated by cyclin B1 in MDA-MB-231 cells treated with AMP. Also, it was observed that cyclin B1 overexpression attenuated cell apoptosis and weakened the inhibitory effects of AMP on cell proliferation. Together, AMP could inhibit breast cancer MDA-MB-231 cell proliferation in vitro and in vivo, due to cell cycle arrest at G2/M by inactivating PI3K/AKT/mTOR pathway regulated by cyclin B1. |
| format | Article |
| id | doaj-art-f95aa9d50f2b4c6fa54fcdf747bab2c2 |
| institution | Kabale University |
| issn | 1846-9558 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Acta Pharmaceutica |
| spelling | doaj-art-f95aa9d50f2b4c6fa54fcdf747bab2c22025-02-03T07:26:16ZengSciendoActa Pharmaceutica1846-95582023-03-01731759010.2478/acph-2023-0005Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivoMeng Minjun0Yang Qiaolu1Ouyang Zhong2Yang Qingmo3Wu Xinyi4Huang Yufan5Su Yonghui6Chen Shuanglong7Chen Wenlin8Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, Xiamen, Fujian P. R. ofChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, P. R. of ChinaBreast cancer is one of the most common malignant tumors in women and it is the most frequently diagnosed cancer in the world. Ampelopsin (AMP) is a purified component from the root of Ampelopsis grossedentata. It is reported that AMP could significantly inhibit the proliferation of breast cancer cells. However, the antitumor mechanism against breast cancer has not yet been fully elucidated. The purpose of this work was to study the role of AMP against breast cancer MDA-MB-231 cells and to further investigate the underlying mechanism. PI3K/AKT/mTOR plays a very important role in tumor cell growth and proliferation and we hypothesize that AMP may inhibit this pathway. In the present work, the results showed that AMP could significantly inhibit the growth of breast cancer MDA-MB-231 cells in vitro and in vivo. In addition, treatment with AMP decreased the levels of PI3K, AKT and mTOR, as well as cyclin B1 expression, followed by p53/p21 pathway activation to arrest the cell cycle at G2/M. Moreover, it demonstrated a positive association between cyclin B1 and PI3K/AKT/mTOR levels. Importantly, this pathway was found to be regulated by cyclin B1 in MDA-MB-231 cells treated with AMP. Also, it was observed that cyclin B1 overexpression attenuated cell apoptosis and weakened the inhibitory effects of AMP on cell proliferation. Together, AMP could inhibit breast cancer MDA-MB-231 cell proliferation in vitro and in vivo, due to cell cycle arrest at G2/M by inactivating PI3K/AKT/mTOR pathway regulated by cyclin B1.https://doi.org/10.2478/acph-2023-0005pi3k/akt/mtor pathwaycyclin b1breast cancercell cycle arrestampelopsin |
| spellingShingle | Meng Minjun Yang Qiaolu Ouyang Zhong Yang Qingmo Wu Xinyi Huang Yufan Su Yonghui Chen Shuanglong Chen Wenlin Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo Acta Pharmaceutica pi3k/akt/mtor pathway cyclin b1 breast cancer cell cycle arrest ampelopsin |
| title | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| title_full | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| title_fullStr | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| title_full_unstemmed | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| title_short | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| title_sort | ampelopsin induces mda mb 231 cell cycle arrest through cyclin b1 mediated pi3k akt mtor pathway in vitro and in vivo |
| topic | pi3k/akt/mtor pathway cyclin b1 breast cancer cell cycle arrest ampelopsin |
| url | https://doi.org/10.2478/acph-2023-0005 |
| work_keys_str_mv | AT mengminjun ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT yangqiaolu ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT ouyangzhong ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT yangqingmo ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT wuxinyi ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT huangyufan ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT suyonghui ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT chenshuanglong ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo AT chenwenlin ampelopsininducesmdamb231cellcyclearrestthroughcyclinb1mediatedpi3kaktmtorpathwayinvitroandinvivo |